Fabian Berkemeier studied economic engineering with a specialization on health technology at the Technical University of Berlin and the KTH Royal Institute of Technology (Stockholm, Sweden). He joined IGES in 2015 and his work focuses on strategic market access consulting for highly innovative therapies incorporating health outcomes, health economics, policy, and stakeholder engagement. He also has experience in strategic consulting for the preparation of dossiers for early benefit assessment as well as comprehensive knowledge of the AMNOG process. Parallel to his work for IGES Institute, Fabian conducts Ph.D. research on the effects of drug regulation at Berlin Institute of Technology and the University of California Berkeley.
Prior to joining IGES, Fabian collected experience in the fields of market access (top 10 pharmaceutical manufacturer) and health politics (German ministry of health). Before turning to pharmaceuticals, Fabian has worked as product manager in the United States and he looks back on multiple years of project management experience.